Repurposing metformin for cardiovascular disease

Graham Rena; Chim C. Lang

doi:10.1161/CIRCULATIONAHA.117.031735

Repurposing metformin for cardiovascular disease

Graham Rena (Lead / Corresponding author)
, Chim C. Lang (Lead / Corresponding author)

Postgraduate Medicine

Research output: Contribution to journal › Article › peer-review

131 Citations (Scopus)

783 Downloads (Pure)

Original language	English
Pages (from-to)	422-424
Number of pages	3
Journal	Circulation
Volume	137
Issue number	5
Early online date	29 Jan 2018
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.117.031735
Publication status	Published - 30 Jan 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cardiovascular diseases
diabetes mellitus
metabolic syndrome
metformin
randomized controlled trial
type 2

Access to Document

10.1161/CIRCULATIONAHA.117.031735

Accepted Author ManuscriptAccepted author manuscript, 65.9 KBLicence: No Licence / Unknown
Author Accepted Manuscript: TableAccepted author manuscript, 57.7 KBLicence: No Licence / Unknown

REnal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop DiurEtics in Diabetic Patients with Chronic Heart Failure (RECEDE-CHF)
Lang, C. (Investigator), McCrimmon, R. (Investigator), Mordi, I. (Investigator), Singh, J. (Investigator) & Struthers, A. (Investigator)
British Heart Foundation
29/07/16 → 28/01/19
Project: Research
Moving Towards a New Personalised Medicine Approach to Primary Prevention in Diabetes: The First Steps
Dow, E. (Investigator), Lang, C. (Investigator), McCrimmon, R. (Investigator) & Struthers, A. (Investigator)
5/08/15 → 4/09/17
Project: Research
MetfoRmin and its Effects on Myocardial Dimension and Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease (MET-REMODEL Trial)
George, J. (Investigator), Houston, G. (Investigator), Lang, C. (Investigator) & Struthers, A. (Investigator)
British Heart Foundation
1/10/14 → 31/12/17
Project: Research

How to Improve Circulation
Rena, G.
11/05/21
1 Media contribution
Press/Media: Other

Cite this

@article{a9d2d88c2cd146c4ba6744ac29351e88,

title = "Repurposing metformin for cardiovascular disease",

keywords = "cardiovascular diseases, diabetes mellitus, metabolic syndrome, metformin, randomized controlled trial, type 2",

author = "Graham Rena and Lang, \{Chim C.\}",

note = "G. Rena acknowledges lab support through The Cunningham Trust, the UK Medical Research Council and the Diabetes UK RW and JM Collins studentship. C.C. Lang acknowledges support from the British Heart Foundation (grant number PG/06/143/21897 and PG/14/4/30539) and the European Foundation for the Study of Diabetes (EFSD) Clinical Diabetes Research Programme in Macrovascular Complications of Diabetes.",

year = "2018",

month = jan,

day = "30",

doi = "10.1161/CIRCULATIONAHA.117.031735",

language = "English",

volume = "137",

pages = "422--424",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Repurposing metformin for cardiovascular disease

AU - Rena, Graham

AU - Lang, Chim C.

N1 - G. Rena acknowledges lab support through The Cunningham Trust, the UK Medical Research Council and the Diabetes UK RW and JM Collins studentship. C.C. Lang acknowledges support from the British Heart Foundation (grant number PG/06/143/21897 and PG/14/4/30539) and the European Foundation for the Study of Diabetes (EFSD) Clinical Diabetes Research Programme in Macrovascular Complications of Diabetes.

PY - 2018/1/30

Y1 - 2018/1/30

KW - cardiovascular diseases

KW - diabetes mellitus

KW - metabolic syndrome

KW - metformin

KW - randomized controlled trial

KW - type 2

U2 - 10.1161/CIRCULATIONAHA.117.031735

DO - 10.1161/CIRCULATIONAHA.117.031735

M3 - Article

C2 - 29378754

SN - 0009-7322

VL - 137

SP - 422

EP - 424

JO - Circulation

JF - Circulation

IS - 5

ER -

Repurposing metformin for cardiovascular disease

UN SDGs

Keywords

Access to Document

Projects

REnal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop DiurEtics in Diabetic Patients with Chronic Heart Failure (RECEDE-CHF)

Moving Towards a New Personalised Medicine Approach to Primary Prevention in Diabetes: The First Steps

MetfoRmin and its Effects on Myocardial Dimension and Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease (MET-REMODEL Trial)

Press/Media

How to Improve Circulation

Cite this